Lantheus Holdings, Inc. Asset Retirement Obligation, Liabilities Incurred
Lantheus Holdings, Inc. (LNTH) reported Asset Retirement Obligation, Liabilities Incurred of $20.40 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Asset Retirement Obligations
us-gaap:AssetRetirementObligationLiabilitiesIncurred · last filed 2026-02-26
- Lantheus Holdings, Inc. asset retirement obligation, liabilities incurred for the quarter ending 2025-12-31 was $0.00.
- Lantheus Holdings, Inc. asset retirement obligation, liabilities incurred for the quarter ending 2025-09-30 was $0.00.
- Lantheus Holdings, Inc. asset retirement obligation, liabilities incurred for fiscal 2025 was $20.40M.
- Lantheus Holdings, Inc. asset retirement obligation, liabilities incurred for fiscal 2014 was $277.00K.
| Period end | Asset Retirement Obligation, Liabilities Incurred 3 month | Asset Retirement Obligation, Liabilities Incurred 6 month | Asset Retirement Obligation, Liabilities Incurred 9 month | Asset Retirement Obligation, Liabilities Incurred 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $20.40M 10-K · filed 2026-02-26 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $20.40M 10-Q · filed 2025-11-06 | ||
| 2025-06-30 | $20.40M 10-Q · filed 2025-08-06 | |||
| 2014-12-31 | $277.00K 10-K · filed 2016-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |